Enovix: Product Commercialization And High Prices Could Drive Shares Down

Discover why Enovix (ENVX) stock is rated Sell amid weak financials and lacking contracts. Learn if strategic changes could ...
Fierce Pharma

GSK makes nice with antifungal partner Scynexis with $22M payment to resolve trial dispute

Brexafemme (ibrexafungerp) partners GSK and Scynexis have worked out their quarrel related to a clinical trial that was previously put on hold, leaving Scynexis with a $22 million payout. | Through ...

BeOne Medicines: Sonrotoclax Could Set Next Stage Of Growth For Hematology Pipeline

BeOne Medicines AG earns Strong Buy rating as BRUKINSA drives growth and pipeline advances. Click here to find out why ONC ...

Cellionyx Exits Stealth Mode with Cytomotion, an FDA-Registered Class I Electroceutical Device Set to Redefine Human Healing and Performance

Cellionyx, a pioneering electroceuticals company, today officially emerged from stealth mode to announce the commercial launch of its flagship product, Cytomotion. Following years of intensive ...